Koki Kunitake

Koki Kunitake

Auto-generated profile, based on publicly available information

Koki Kunitake

Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
KKKoki Kunitake
Koki Kunitake
TMTadahaya Mizuno
Tadahaya Mizuno
KHKazuki Hattori
Kazuki Hattori
COChitose Oneyama
Chitose Oneyama
MKMako Kamiya
Mako Kamiya
RKRyosuke Kojima
Ryosuke Kojima
Small extracellular vesicles (sEVs) are important intercellular information transmitters in various biological contexts, but their release processes remain poorly understood. Herein, we describe a high-throughput assay platform, CRISPR-assisted individually barcoded sEV-based release regulator (CIBER) screening, for identifying key players in sEV release. CIBER screening employs sEVs barcoded with CRISPR-gRNA through the interaction of gRNA and dead Cas9 fused with an sEV marker. Barcode quantification enables the estimation of the sEV amount released from each cell in a massively parallel manner. Barcoding sEVs with different sEV markers in a CRISPR pooled-screening format allows genome-wide exploration of sEV release regulators in a subpopulation-specific manner, successfully identifying previously unknown sEV release regulators and uncovering the exosomal/ectosomal nature of CD63+/CD9+ sEVs, respectively, as well as the synchronization of CD9+ sEV release with the cell cycle. CIBER should be a valuable tool for detailed studies on the biogenesis, release, and heterogeneity of sEVs.

20 February 2026 in Science Advances
Verified
Journal Article
Open access
SKShota Kawaguchi
Shota Kawaguchi
TATaiga Ajiri
Taiga Ajiri
RMRina Mitsuya
Rina Mitsuya
RTReiko Tsuchiya
Reiko Tsuchiya
KKKoki Kunitake
Koki Kunitake
TYTakao Yasui
Takao Yasui
Urinary small extracellular vesicles (sEVs), which can reflect systemic conditions, hold great promise for noninvasive cancer diagnostics, yet the mechanism by which tumor-derived sEVs reach urine remains unclear. Here, we demonstrate that the glomerulus actively transcytoses circulating tumor-derived sEVs into urine. Using CRISPR guide RNA–tagged glioma sEVs and bioluminescent/fluorescent green-enhanced nano-lantern (GeNL)–tagged lung and pancreatic cancer sEVs, we tracked their journey from tumors to urine in multiple mouse models. In vivo and in vitro analyses revealed endocytic uptake and transcytotic release by glomerular cells, accompanied by changes in sEV size and surface composition. GeNL-tagged sEVs consistently showed higher signals in urine than plasma, indicating selective excretion. These findings redefine the glomerulus as a dynamic regulator of sEV processing and establish a mechanistic foundation for urinary liquid biopsy.

28 September 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
KKKoki Kunitake
Koki Kunitake
TMTadahaya Mizuno
Tadahaya Mizuno
KHKazuki Hattori
Kazuki Hattori
COChitose Oneyama
Chitose Oneyama
MKMako Kamiya
Mako Kamiya
RKRyosuke Kojima
Ryosuke Kojima
Small extracellular vesicles (sEVs) are important intercellular information transmitters in various biological contexts, but their release processes remain poorly understood. Herein, we describe a high-throughput assay platform, C RISPR-assisted individually b arcoded s E V-based release r egulator (CIBER) screening, for identifying key players in sEV release. CIBER screening employs sEVs barcoded with CRISPR-gRNA through the interaction of gRNA and dead Cas9 fused with an sEV marker. Barcode quantification enables the estimation of the sEV amount released from each cell in a massively parallel manner. Barcoding sEVs with different sEV markers in a CRISPR pooled-screening format allows genome-wide exploration of sEV release regulators in a subpopulation-specific manner, successfully identifying previously unknown sEV release regulators and uncovering the exosomal/ectosomal nature of CD63 + /CD9 + sEVs, respectively, as well as the synchronization of CD9 + sEV release with the cell cycle. CIBER should be a valuable tool for detailed studies on the biogenesis, release, and heterogeneity of sEVs.